Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap™ Platform at Digestive Disease Week 2024
Biora TherapeuticsBiora Therapeutics(US:BIOR) globenewswire.com·2024-05-20 12:00

SAN DIEGO, May 20, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, presented a poster titled "Results of human device function studies for the NaviCap™ Targeted Oral Delivery Platform in healthy volunteers and patients with UC" at the Digestive Disease Week® conference in Washington DC, on Sunday, May 19, 2024. "In four separate clinical studies, we evaluated the functionality and safety of the NaviCap device in healthy particip ...

Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap™ Platform at Digestive Disease Week 2024 - Reportify